Your Unread Messages in EndocrinologySee All >> Messages include industry-sponsored communications and special communications from MDLinx
Smartest Doc Challenge
And the winner is...
M3 Global Research
Get paid for your medical opinions today!
Follow your favorite authors + Social Sharing Tools
1 Association between sugar-sweetened beverages and type 2 diabetes: a meta-analysis Journal of Diabetes Investigation, November 13, 2014 Evidence Based Medicine Review Article
2 Chemical in coffee may help prevent obesity-related disease University of Georgia Research News, November 18, 2014
3 Liraglutide and the preservation of pancreatic β-cell function in early type 2 diabetes: The LIBRA Trial Diabetes Care, September 26, 2014
4 The effect of proton pump inhibitors on glycated hemoglobin levels in patients with type 2 diabetes mellitus Canadian Journal of Diabetes, October 28, 2014 Review Article
5 Retrospective study of adherence to glucagon-like peptide-1 receptor agonist therapy in patients with type 2 diabetes mellitus in the United States Advances in Therapy, November 21, 2014
6 Dual add-on therapy in type 2 diabetes poorly controlled with metformin monotherapy: a randomized double-blind trial of saxagliptin plus dapagliflozin addition versus single addition of saxagliptin or dapagliflozin to metformin Diabetes Care, November 4, 2014
7 Are sulfonylurea and insulin therapies associated with a larger risk of cancer than metformin therapy? A retrospective database analysis Diabetes Care, October 24, 2014
8 Postprandial dynamics of plasma glucose, insulin, and glucagon in patients with type 2 diabetes treated with saxagliptin plus dapagliflozin add-on to metformin therapy Endocrine Practice, November 7, 2014
9 Efficacy and safety of dapagliflozin monotherapy in people with Type 2 diabetes: a randomized double-blind placebo-controlled 102-week trial Diabetic Medicine, November 12, 2014
10 A randomized, double-blind, placebo-controlled, phase II clinical trial to investigate the efficacy and safety of oral DA-1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exercise Diabetes/Metabolism Research and Reviews, November 6, 2014